about
The acute phase protein Serum Amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathwaysInternational Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyToll-like Receptors in Ovarian Cancer as Targets for ImmunotherapiesSerum amyloid A induces interleukin-33 expression through an IRF7-dependent pathwayHepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in miceEx vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophilsSAA does not induce cytokine production in physiological conditionsCutting edge: TLR2 is a functional receptor for acute-phase serum amyloid ASerum amyloid A: an acute-phase protein involved in tumour pathogenesisSerum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cellsHuman SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivoSecretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism.Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi.Induction of pro-inflammatory genes by serum amyloid A1 in human amnion fibroblastsIntestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis.Increased inducible nitric oxide synthase expression in organs is associated with a higher severity of H5N1 influenza virus infection.A pertussis toxin sensitive G-protein-independent pathway is involved in serum amyloid A-induced formyl peptide receptor 2-mediated CCL2 production.Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages.DAMPening inflammation by modulating TLR signalling.High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2.Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonistsS100A12 suppresses pro-inflammatory, but not pro-thrombotic functions of serum amyloid A.Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties.Serum amyloid A in the placenta and its role in trophoblast invasion.Toll-like receptor 4 activation in cancer progression and therapySerum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary diseaseSerum amyloid A overrides Treg anergy via monocyte-dependent and Treg-intrinsic, SOCS3-associated pathways.Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes.Serum amyloid A in uremic HDL promotes inflammationSerum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory virus infection.Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophagesUp-regulated S100 calcium binding protein A8 in Plasmodium-infected patients correlates with CD4(+)CD25(+)Foxp3 regulatory T cell generation.Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance.Serum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE ReceptorsHepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartanHigh-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA2-IIE and sPLA2-V Expression in Macrophages.
P2860
Q24317321-C41FF07E-BE35-4044-86C5-D885AFD2D5ADQ24652940-8925A0C3-A771-47AC-99D1-0E25A90EB233Q26861234-CF81ED28-0337-4ABC-BFCF-61A644EAC88FQ28239055-19A62DCF-8929-412D-ADBE-F37164DD43C4Q28260051-1EFFECBE-D0CA-434E-B33F-CCDC7B289FBFQ28260398-02777987-E327-438B-9D70-CD0F9E684EEAQ28279562-BDB2DFF6-A518-4361-A278-908142FFFC19Q28284501-E3B37B35-B557-487D-989E-EAFAD568EA68Q28291806-CA920026-62F9-49D3-8DC4-4F895BEC4480Q28298733-0CD2A696-0A5F-4A03-AA61-619D0D056C3DQ28580132-7EEEC44D-5FA4-4D77-A4A2-A5883CFB277CQ33579601-2060B2BC-C0BD-42B6-928B-32797C77F298Q33581415-9047FFD4-9783-4653-A594-BA394CE8C04DQ33601917-DD3B18A8-B328-433C-B62C-32A53CD5449FQ33677454-21183F12-74E8-498D-9C02-F306FFE08643Q33743503-D6C2885B-5EE6-43DD-94F2-98E523E7B90FQ33808545-7B51FE93-1ABE-4746-B53C-0D68DD7F67C7Q33809151-58E788C6-11BB-436B-8E2B-FB0AF7A2CC53Q33922619-85D49D6F-552B-4DC3-991C-004CF7370259Q34035570-41274FDE-2324-4577-AFBA-B09E9325EA42Q34157008-0E6CD60A-17C8-445F-A00C-1FA7172EA21DQ34615520-B66D6FE8-45B9-4ABF-90C6-7272BDA5DAA7Q34645842-18700C0C-8294-4E50-8CF9-BC9BBF720546Q34701317-EED760AD-ABB2-4BF4-B125-2375BEAD2C97Q34776878-D378A465-7C45-4305-AD90-90413A937C49Q35116147-578F8CB3-9643-49DD-B336-DB0DCD5F1CC4Q35550677-C1F58056-1793-482F-A31D-7019C57540E1Q35723642-A5DFCD34-9FE0-4E7F-B046-CF4297FF886CQ35734988-66036AAE-1898-4B09-AB7E-55AA28A2AD76Q35812125-E0B6C63B-4691-42A5-B4E3-502CC503D09DQ35897585-D22E002B-BAB1-4AD6-A661-07F3D35E7757Q35917487-0704631C-72B9-4007-A7C3-2FA625278C40Q35944077-E3224713-42D6-4B52-946C-1EE938F02BC2Q35952327-BB3F30E9-2667-4223-9F18-C827A802508AQ36084261-901B0599-E1F8-49DE-9880-AD9B80024A3AQ36126345-C583AF48-FF9D-4FD0-9981-D41D0CA02D9CQ36166890-4C132865-DDC6-4C2E-A0EA-97A417A8B1BCQ36167046-F0BED03D-0269-4037-A616-6C19F706902BQ36167581-F3937DAF-6697-47A5-BB97-CC57C2BB257BQ36206946-E0E95C66-0224-4FAD-BC97-380301B69141
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Is serum amyloid A an endogenous TLR4 agonist?
@ast
Is serum amyloid A an endogenous TLR4 agonist?
@en
Is serum amyloid A an endogenous TLR4 agonist?
@nl
type
label
Is serum amyloid A an endogenous TLR4 agonist?
@ast
Is serum amyloid A an endogenous TLR4 agonist?
@en
Is serum amyloid A an endogenous TLR4 agonist?
@nl
prefLabel
Is serum amyloid A an endogenous TLR4 agonist?
@ast
Is serum amyloid A an endogenous TLR4 agonist?
@en
Is serum amyloid A an endogenous TLR4 agonist?
@nl
P2093
P356
P1476
Is serum amyloid A an endogenous TLR4 agonist?
@en
P2093
Dunia Rodriguez
Eliane Gomes
Hugo Pequeno Monteiro
Momtchilo Russo
Silvana Sandri
P304
P356
10.1189/JLB.0407203
P407
P577
2008-05-01T00:00:00Z